It confirmed a diagnosis of hypereosinophilic syndrome with the FIP1L1‐PDGFRA fusion gene, indicating myeloid neoplasm with eosinophilia and PDGFR-A rearrangement. Here, PDGFRA is linked to myeloid neoplasm.